I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 13 studies | 23% ± 7% | |
| natural killer cell | 9 studies | 19% ± 3% | |
| macrophage | 9 studies | 24% ± 6% | |
| oligodendrocyte | 8 studies | 28% ± 10% | |
| astrocyte | 7 studies | 29% ± 9% | |
| CD16-positive, CD56-dim natural killer cell, human | 6 studies | 18% ± 1% | |
| classical monocyte | 5 studies | 25% ± 7% | |
| non-classical monocyte | 5 studies | 25% ± 8% | |
| B cell | 5 studies | 20% ± 5% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 17% ± 2% | |
| microglial cell | 5 studies | 25% ± 9% | |
| epithelial cell | 5 studies | 30% ± 9% | |
| glutamatergic neuron | 5 studies | 43% ± 12% | |
| oligodendrocyte precursor cell | 5 studies | 29% ± 9% | |
| monocyte | 5 studies | 21% ± 3% | |
| fibroblast | 4 studies | 20% ± 4% | |
| endothelial cell of lymphatic vessel | 4 studies | 20% ± 3% | |
| GABAergic neuron | 4 studies | 36% ± 10% | |
| interneuron | 4 studies | 35% ± 17% | |
| conventional dendritic cell | 3 studies | 34% ± 12% | |
| hematopoietic precursor cell | 3 studies | 23% ± 6% | |
| myeloid cell | 3 studies | 26% ± 4% | |
| ciliated cell | 3 studies | 23% ± 2% | |
| lymphocyte | 3 studies | 21% ± 1% | |
| dendritic cell | 3 studies | 32% ± 10% | |
| alveolar macrophage | 3 studies | 21% ± 6% | |
| basal cell | 3 studies | 20% ± 3% | |
| neuron | 3 studies | 37% ± 7% | |
| naive B cell | 3 studies | 17% ± 1% | |
| plasmacytoid dendritic cell | 3 studies | 19% ± 3% |
